[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100636716":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":26,"centralContacts":31,"locations":37,"responsibleParty":55,"collaborators":26,"id":57,"slug":58,"hasResults":59,"nctId":60,"briefTitle":61,"officialTitle":62,"acronym":26,"eligibilityCriteria":63,"healthyVolunteers":59,"sex":64,"minAge":65,"maxAge":66,"enrollmentInfo":67,"targetDuration":26,"studyType":70,"phases":71,"briefSummary":73,"conditions":74,"keywords":76,"overallStatus":81,"whyStopped":26,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"Bedaya Hospital","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Modified dual trigger group","EXPERIMENTAL","HCG is administered 36 hours before ovum pickup and two successive doses of GnRH are administered 36 and 24 hours before ovum pickup.",[13],"Drug: Modified dual trigger",{"label":15,"type":16,"description":17,"interventionNames":18},"HCG group","ACTIVE_COMPARATOR","A single dose of HCG is administered 36 hours before oocyte retrieval",[19],"Drug: HCG",[21,27],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DRUG","Modified dual trigger","HCG (10000 IU \u002FIM) and triptorelin (0.2 mg\u002FS.C) are administered 36 hours before ovum pickup . Moreover, 0.1mg of triptorelin is administered 24 h prior to ovum pick-up.",[9],null,{"type":22,"name":28,"description":29,"armGroupLabels":30,"otherNames":26},"HCG","HCG (10000 IU\u002FIM ) is administered 36 hours before ovum pickup.",[15],[32],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},"Usama M Fouda, Prof","CONTACT","+201095401375","umfrfouda@yahoo.com",[38],{"facility":5,"status":26,"city":39,"state":40,"zip":41,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Giza","Giza Governorate","3753303","Egypt","EG",{"type":45,"coordinates":46},"Point",[47,48],31.20861,30.00944,{"lat":48,"lon":47},[51,52],{"name":33,"role":34,"phone":35,"phoneExt":26,"email":36},{"name":53,"role":54,"phone":26,"phoneExt":26,"email":26},"Amira Alasmar, M.D, PhD","PRINCIPAL_INVESTIGATOR",{"type":56,"investigatorFullName":26,"investigatorTitle":26,"investigatorAffiliation":26,"oldNameTitle":26,"oldOrganization":26},"SPONSOR","100636716","phase-2-triggering-ovulation-in-normo-responders-using-a-modified-dual-trigger-protocol-or-hcg-trigger-100636716",false,"NCT07569302","Triggering Ovulation in Normo-responders Using a Modified Dual Trigger Protocol or HCG Trigger","Triggering Ovulation in Normo-responders Using a Modified Dual Trigger Protocol or HCG Trigger . A Randomized Controlled Study","Inclusion Criteria:\n\n* GnRH antagonist IVF cycle\n* Normo-responders to induction of ovulation\n\nExclusion Criteria:\n\n* Hypogonadotrophic hypogonadism\n* Endometriosis\n* History of recurrent abortion","FEMALE","18 Years","40 Years",{"count":68,"type":69},196,"ESTIMATED","INTERVENTIONAL",[72],"PHASE2","The aim of this randomized controlled study is to compare the efficacy of a modified dual trigger protocol \\[a single bolos of HCG combined with two successive doses of a GnRH agonist \\] with HCG \\[a single bolos administered 36 hours before oocyte retrieval \\] in triggering ovulation in normo-responders undergoing ovarian stimulation using the antagonist protocol.",[75],"Infertility (IVF Patients)",[77,78,79,80,28],"Infertility","IVF-ET","Normo-responders","GnRH agonist","NOT_YET_RECRUITING","2026-04-29",{"date":84,"type":85},"2026-05-06","ACTUAL",{"date":87,"type":69},"2026-06-01",{"date":89,"type":69},"2028-04-01",{"name":5,"class":6},1]